Clairvoyant Therapeutics Receives Approval in Canada to Initiate a World-leading Psilocybin Trial for Treatment of Alcohol Use Disorder
VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Clairvoyant Therapeutics, a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased